Details of the Drug Reposition

General Information of This Drug (ID: DMPCGY3)

• Drug Name: RPTR-147 (DMPCGY3)
• Drug Type: Cell therapy

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Solid tumour/cancer	DISZR48F	2A00-2F9Z	Phase 1	[1]
Lymphoma	DISN6V4S	2A80-2A86	Phase 1	[1]

References

• [1] ClinicalTrials.gov (NCT03815682) RPTR-147 in Patients With Selected Solid Tumors and Lymphomas. U.S. National Institutes of Health.